All
Merck KGaA Invests in China, Global HQ
Merck KGaA plans to build a new biomanufacturing facility in Nantong, China.
CareFusion Expands Specialty Disposables Business with Acquisition from GE Healthcare
CareFusion will acquire GE Healthcare’s Vital Signs division.
Pfizer and GlaxoSmithKline Form Pact in Combination Cancer Trial
Phase I/II study to evaluate treatment of patients with melanoma using Pfizer's spalbociclib and GSK's trametinib.
Pfizer to Close Manufacturing Plant in Puerto Rico by 2017
Manufacturing of products made at the Barceloneta, Puerto Rico plant will be moved to other sites.
Unilife to Supply Hikma with Prefilled Syringes for Generic Injectables
Unilife to begin commercial supply in 2014.
Pharmaceutical Industry Growth Rebounds in Five-Year Outlook
Annual growth in spending for medicines is expected to rise from 2-3% in 2013 to 5-7% in 2017, the highest pace of growth since 2009.
GlaxoSmithKline Invests in India
GlaxoSmithKline will build a new solid dosage manufacturing facility in India.
Catalent Signs RL21 Anti-Cancer Development Deal with Pure MHC
Catalent has signed a product development agreement with immunology company Pure MHC (major histocompatibility complex), which specializes in MHC-based diagnostics and therapeutics.
EMA Signs 3-Year Work Plan with EUnetHTA
Plan outlines key areas of collaboration.
Operational Excellence Improves Quality and Compliance
An operational-excellence initiative increased collaboration between operations and quality personnel to address human-error-caused deviations.
Patheon to Merge with DSM Pharmaceutical Products
New CDMO to be formed from the combination of DSM Pharmaceutical Products and Patheon in a $2.6-billion transaction.
Xcelience Appoints Clinical Supplies VP of New UK Site
Xcelience appoints Clinical Supplies VP of its new Birmingham, United Kingdom site.
USP Seeks Experts for 2015-2020 Council of Experts
USP issues call for candidates for its 2015-2020 Council of Experts.
Collaboration Uses Next-Gen Sequencing for Biosafety Assessments
Covance Inc. and Pathoquest have announced a collaboration to provide next-generation sequencing (NGS) based biosafety assessments to detect and identify viral contaminants within biologic compounds.
Eli Lilly Plans Insulin Manufacturing Investments
Ei Lilly announces investments in insulin manufacturing capacity for its sites in Indianapolis, Puerto Rico, France, and China.
Intertek Launches Comprehensive Inhalation Product Development Services
Intertek is now offering comprehensive services for the development of orally inhaled and intranasal drug products (OINDPs) for both small molecules and biologics.
Telstar Develops High-Containment Barrier Systems for Komipharm
The systems are designed for the manufacture of oncology products and to research new biotech products.
AAPS Announces Award Winners
Association recognizes groundbreaking researchers in the field of pharmaceutical sciences.
Shire To Acquire Rare-Disease Company ViroPharma
Shire-s agreement to acquire ViroPharma will strengthen its rare-disease portfolio.
AstraZeneca to Invest in New Manufacturing Facility for Injectable Drug
AstraZeneca will build a new facility in the United Kingdom to produce Zoladex, an injectable prostrate cancer treatment.
Grifols Purchases Novartis Transfusion Diagnostics Unit
Grifols expands and diversifies portfolio with acquisition of diagnostic business.
DCAT Names Officers
Lyra Myers, associate director and value creation agent at Roche, has been elected DCAT president.
Pfizer, Carter Center Partner in Global Health Project
Former President Jimmy Carter and Pfizer mark milestone for long-standing partnership to combat trachoma in the developing world.
Generic Drug Super Office Takes Shape
Catalent Introduces New Web Tool To Solve Formulation Challenges
New interactive web tool helps innovators match formulations to drug delivery technologies.
Breakthrough Therapies Raise Manufacturing Issues
FDA Promotes Personalized Medicine
Shire To Axe Jobs In UK
The restructuring will put more than 100 R&D jobs at risk as the company scales back on drug development with the aim of simplifying its business to focus on rare disease.
FDA Moves to Curb Drug Shortages
BIO Throws its Support for Start-up Jobs and Innovation Act
Biotechnology Industry Organization President James Greenwood writes senators in support of Start-up Jobs and Innovation Act.
